27 February 2019
Pioneer Credit (PNC)Reaching FY19 Guidance is KeyRecommendationBuy (unchanged)Price$2.17Target (12 months)$2.86 (previously $4.35)AnalystLafitani Sotiriou 613 9235 1668AuthorisationTS Lim 612 8224 2810GICS SectorDiversified FinancialsExpected ReturnCapital growth 31.8%Dividend yield 6.4%Total expected return 38.2%Company Data & RatiosEnterprise value $130mMarket cap $134mIssued capital 63.2mFree float 82.3%Avg. daily val. (52wk) $359,50512 month price range $2.17 - $3.78Price PerformanceBELL POTTER SECURITIES.
A bump in the roadPNC has delivered a disappointing 1H19 result, with NPAT falling below expectations,and with the auditor providing a qualification of the result being a review and not a fullaudit as the information provided and time was limited. However, the company hasreiterated its FY19 guidance which implies a meaningful recovery in 2H19. It appearsthe liquidations of recent purchased books aren’t reaching expectations, but thecompany is confident of a rebound.PNC has guided to full year NPAT of greater than $20m, which compares to the $5.5machieved in 1H19, and to our revised FY19 estimate of $17.8m.
We view the 1H19update as a bump in the road for PNC and if it can show a recovery in 2H19, there ismeaningful upside on offer. Other guidance includes PDP investment of $80m forFY19, and liquidations greater than $120m.Result highlights 1H19 NPAT of $5.5m, below our $9.6m estimate; Interim dividend of 4.31cps, below our 6.9cps estimate; PDP liquidations below company expectations in 1H19, but the company hasguided to a bounce in 2H19; and PNC moving away from small loans.Earnings revisionsFollowing PNC’s 1H19 result we have downgraded our underlying EPS by -15.3%, -25.6% and -33.0% for FY19, FY20 and FY21. The earnings revision is driven by the1H19 results miss.Following our earnings revisions, our revised Price Target is $2.86 per share(previously $4.85 per share), with our Buy recommendation remaining unchanged.
- Forums
- ASX - By Stock
- Ann: 1H19 Media Release
27 February 2019Pioneer Credit (PNC)Reaching FY19 Guidance is...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNC (ASX) to my watchlist
(20min delay)
|
|||||
Last
63.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.69M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8333 | 60.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
61.0¢ | 15000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 62500 | 0.480 |
1 | 36200 | 0.470 |
1 | 1816 | 0.465 |
1 | 20000 | 0.460 |
1 | 10000 | 0.455 |
Price($) | Vol. | No. |
---|---|---|
0.490 | 47333 | 1 |
0.500 | 3000 | 1 |
0.505 | 432 | 1 |
0.510 | 85615 | 2 |
0.520 | 904 | 1 |
Last trade - 09.55am 18/11/2024 (20 minute delay) ? |
Featured News
PNC (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online